WO2010061284A3 - A controlled release intravaginal polymeric pharmaceutical dosage form - Google Patents

A controlled release intravaginal polymeric pharmaceutical dosage form Download PDF

Info

Publication number
WO2010061284A3
WO2010061284A3 PCT/IB2009/007583 IB2009007583W WO2010061284A3 WO 2010061284 A3 WO2010061284 A3 WO 2010061284A3 IB 2009007583 W IB2009007583 W IB 2009007583W WO 2010061284 A3 WO2010061284 A3 WO 2010061284A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage form
controlled release
pharmaceutical dosage
polymeric pharmaceutical
release intravaginal
Prior art date
Application number
PCT/IB2009/007583
Other languages
French (fr)
Other versions
WO2010061284A2 (en
Inventor
Valence M.K. Ndesendo
Viness Pillay
Yahya Essop Choonara
Original Assignee
University Of Witwatersrand, Johannesburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Witwatersrand, Johannesburg filed Critical University Of Witwatersrand, Johannesburg
Priority to AP2011005773A priority Critical patent/AP3204A/en
Publication of WO2010061284A2 publication Critical patent/WO2010061284A2/en
Publication of WO2010061284A3 publication Critical patent/WO2010061284A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Abstract

This invention relates to a controlled release, intravaginal, pharmaceutical dosage form. The dosage form consists of at least one desired pharmaceutically active ingredient which is admixed with a combination of biocompatible and biodegradable polymers and shaped for insertion into the vagina of a patient. The polymers are selected so as to biodegrade at a predetermined rate and, on biodegrading, the pharmaceutically active ingredient is released.
PCT/IB2009/007583 2008-11-30 2009-11-30 A controlled release intravaginal polymeric pharmaceutical dosage form WO2010061284A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AP2011005773A AP3204A (en) 2008-11-30 2009-11-30 A controlled release intravaginal polymeric pharmaceutical dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200805077 2008-11-30
ZA2008/05077 2008-11-30

Publications (2)

Publication Number Publication Date
WO2010061284A2 WO2010061284A2 (en) 2010-06-03
WO2010061284A3 true WO2010061284A3 (en) 2010-10-28

Family

ID=42167983

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/007583 WO2010061284A2 (en) 2008-11-30 2009-11-30 A controlled release intravaginal polymeric pharmaceutical dosage form

Country Status (3)

Country Link
AP (1) AP3204A (en)
WO (1) WO2010061284A2 (en)
ZA (1) ZA200908494B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204016B1 (en) 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Compositions comprising sulfated polysaccharides and uses thereof
EP3355893A4 (en) 2015-09-29 2019-06-12 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
WO2006017238A1 (en) * 2004-07-12 2006-02-16 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea
WO2007035515A2 (en) * 2005-09-15 2007-03-29 Umd, Inc. A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration
WO2007119185A2 (en) * 2006-04-17 2007-10-25 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
WO2006017238A1 (en) * 2004-07-12 2006-02-16 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea
WO2007035515A2 (en) * 2005-09-15 2007-03-29 Umd, Inc. A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration
WO2007119185A2 (en) * 2006-04-17 2007-10-25 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NDESENDO V M K ET AL: "In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL LNKD- DOI:10.1016/J.IJPHARM.2008.12.001, vol. 370, no. 1-2, 31 March 2009 (2009-03-31), pages 151 - 159, XP026001820, ISSN: 0378-5173, [retrieved on 20081207] *

Also Published As

Publication number Publication date
AP2011005773A0 (en) 2011-06-30
ZA200908494B (en) 2010-12-29
AP3204A (en) 2015-03-31
WO2010061284A2 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
WO2010062523A3 (en) Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
WO2007038246A3 (en) Solid polymer delivery compositions and methods for use thereof
WO2006023130A3 (en) Biodegradable controlled release bioactive agent delivery device
NZ603579A (en) Controlled release formulations
WO2008098927A3 (en) Degradable reservoir implants
WO2009094573A3 (en) Linear order release polymer
WO2006039336A3 (en) Conveniently implantable sustained release drug compositions
WO2008070356A3 (en) Block biodegradable copolymers for medical devices
WO2008014191A3 (en) Apparatus and method for manipulating or retracting tissue and anatomical structure
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2007036952A3 (en) Novel sustained release dosage form
WO2011031855A3 (en) Implantable device for controlled drug delivery
WO2008087488A3 (en) Expandable medical device for the treatment and prevention of cardiovascular diseases
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2009005909A3 (en) Biodegradable triblock copolymers for implantable devices
WO2007130134A3 (en) Controlled release microparticles
WO2006083904A3 (en) Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
WO2007133924A3 (en) Biodegradable modified caprolactone polymers for fabricating and coating medical devices
WO2009048594A3 (en) Multicomponent bioactive intravaginal ring
WO2008054772A3 (en) Implantable elastomeric caprolactone depot compositions and uses thereof
MX2009005445A (en) Delivery system for risperidone.
WO2011139595A3 (en) Elongated biodegradable depot for sustained drug release to treat chronic pelvic pain
WO2005000268A3 (en) Bioerodible sustained release drug delivery systems
WO2011112996A3 (en) Injectable drug delivery system
WO2010099292A3 (en) Biodegradable drug or other active delivery system

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09793573

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09793573

Country of ref document: EP

Kind code of ref document: A2